Literature DB >> 7578691

Effect of in vivo gonadotropin treatment on the ability of progesterone, estrogen, and cyclic adenosine 5'-monophosphate to inhibit insulin-dependent granulosa cell mitosis in vitro.

A M Luciano1, J J Peluso.   

Abstract

The ability of progesterone (P4), estradiol-17 beta (E2), and 8-bromo (br)-cAMP to inhibit small granulosa cells (GCs) from undergoing insulin-dependent mitosis was examined. Small GCs were isolated from immature and eCG-primed rats and separated by Percoll fractionation. Small GCs were cultured for 24 h with various combinations of insulin, steroids, steroid receptor antagonists, and 8-br-cAMP. Before and after culture, the number of GCs was counted. Small GC proliferation was expressed as a percentage increase over the initial value P4 inhibited insulin-dependent mitosis of small GCs isolated from both immature and eCG-primed rats. The effects of P4 were dose-dependent, steroid-specific, and reversed by the progesterone antagonist RU486. E2 inhibited insulin-dependent mitosis of small GCs isolated from immature but not eCG-primed rats. The action of E2 was dose-dependent and inhibited by the estrogen antagonist tamoxifen. Additional studies were conducted in which small GCs from immature rats were cultured with insulin in the presence of both P4 and E2 and their respective antagonist. Both antagonists were required for insulin to induce GC mitosis in the presence of P4 and E2. Further, the ability of P4 to suppress insulin-dependent mitosis was reduced if it was not present during the first 6 h of culture. In contrast, E2 could be added up to 12 h after insulin exposure and still completely prevent GC mitosis. 8-br-cAMP also prevented insulin-dependent GC proliferation. The actions of 8-br-cAMP could not be reversed by aminoglutethimide or RU486.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7578691     DOI: 10.1095/biolreprod53.3.664

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  8 in total

Review 1.  Challenges and Potential for Ovarian Preservation with SERMs.

Authors:  Alison Y Ting; Brian K Petroff
Journal:  Biol Reprod       Date:  2015-03-25       Impact factor: 4.285

Review 2.  Non-canonical progesterone signaling in granulosa cell function.

Authors:  John J Peluso; James K Pru
Journal:  Reproduction       Date:  2014-04-08       Impact factor: 3.906

3.  A novel role for progesterone and progesterone receptor membrane component 1 in regulating spindle microtubule stability during rat and human ovarian cell mitosis.

Authors:  Valentina Lodde; John J Peluso
Journal:  Biol Reprod       Date:  2010-12-08       Impact factor: 4.285

4.  Progesterone receptor membrane component 1 and 2 regulate granulosa cell mitosis and survival through a NFΚB-dependent mechanism†.

Authors:  John J Peluso; Cindy A Pru; Xiufang Liu; Nicole C Kelp; James K Pru
Journal:  Biol Reprod       Date:  2019-06-01       Impact factor: 4.285

Review 5.  Progesterone Signaling and Mammalian Ovarian Follicle Growth Mediated by Progesterone Receptor Membrane Component Family Members.

Authors:  John J Peluso
Journal:  Cells       Date:  2022-05-13       Impact factor: 7.666

6.  Plasminogen activator inhibitor 1 RNA-binding protein interacts with progesterone receptor membrane component 1 to regulate progesterone's ability to maintain the viability of spontaneously immortalized granulosa cells and rat granulosa cells.

Authors:  John J Peluso; Angela Yuan; Xiufang Liu; Valentina Lodde
Journal:  Biol Reprod       Date:  2013-01-25       Impact factor: 4.285

Review 7.  The role of steroids in follicular growth.

Authors:  Ann E Drummond
Journal:  Reprod Biol Endocrinol       Date:  2006-04-10       Impact factor: 5.211

8.  The variable success of in vitro maturation: can we do better?

Authors:  Alberto M Luciano; Federica Franciosi; Rodrigo G Barros; Cecilia Dieci; Valentina Lodde
Journal:  Anim Reprod       Date:  2018-08-03       Impact factor: 1.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.